Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile

  • Financials As Reported

    • accession Number 0001048477-23-000020
    • accounts Receivable Net Current 597,913,000
    • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 806,944,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --10,722,000
    • allocated Share Based Compensation Expense 53,695,000
    • amendment Flag false
    • assets 6,433,695,000
    • assets Current 2,842,105,000
    • cash And Cash Equivalents At Carrying Value 580,074,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 580,074,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --144,457,000
    • cik 1,048,477
    • city Area Code 415
    • common Stock Par Or Stated Value Per Share 0.001
    • common Stock Shares Authorized 500,000,000
    • common Stock Shares Issued 187,601,106
    • common Stock Shares Outstanding 187,601,106
    • comprehensive Income Net Of Tax 43,997,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-04-28
    • debt Instrument Carrying Amount 1,100,000,000
    • deferred Income Tax Expense Benefit --6,360,000
    • depreciation 10,300,000
    • depreciation Depletion And Amortization 26,421,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic 0.27
    • earnings Per Share Diluted 0.27
    • entity Address Address Line 1 770 Lindaro Street
    • entity Address City Or Town San Rafael
    • entity Address Postal Zip Code 94,901
    • entity Address State Or Province CA
    • entity Central Index Key 1,048,477
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 000-26727
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name BIOMARIN PHARMACEUTICAL INC
    • entity Registrant Name BioMarin Pharmaceutical Inc
    • entity Shell Company false
    • entity Small Business false
    • entity Tax Identification Number 68-0397820
    • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 56,757,000
    • income Tax Expense Benefit 5,905,000
    • increase Decrease In Accounts Receivable 138,796,000
    • increase Decrease In Inventories 14,098,000
    • increase Decrease In Other Operating Liabilities 4,262,000
    • interest Expense 3,703,000
    • interest Paid Net 1,437,000
    • inventory Net 918,921,000
    • irs Number 680,397,820
    • liabilities 1,774,652,000
    • liabilities And Stockholders Equity 6,433,695,000
    • liabilities Current 598,231,000
    • local Phone Number 506-6700
    • net Cash Provided By Used In Financing Activities --40,742,000
    • net Cash Provided By Used In Investing Activities --30,012,000
    • net Cash Provided By Used In Operating Activities --73,932,000
    • net Income Loss 50,852,000
    • operating Income Loss 59,347,000
    • other Assets Current 173,180,000
    • other Assets Noncurrent 150,057,000
    • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --6,855,000
    • other Liabilities Noncurrent 92,415,000
    • other Noncash Income Expense 222,000
    • payments Related To Tax Withholding For Share Based Compensation 51,422,000
    • payments To Acquire Property Plant And Equipment 24,456,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Gross 1,875,086,000
    • property Plant And Equipment Net 1,068,142,000
    • report Link https://www.sec.gov/Archives/edgar/data/1048477/000104847723000020/bmrn-20230331_htm.xml
    • research And Development Expense 171,846,000
    • retained Earnings Accumulated Deficit --738,347,000
    • revenue From Contract With Customer Excluding Assessed Tax 596,415,000
    • selling General And Administrative Expense 223,003,000
    • share Based Compensation 53,695,000
    • stockholders Equity 4,659,043,000
    • trading Symbol BMRN
    • update 1970-01-01
    • weighted Average Number Of Diluted Shares Outstanding 194,363,000
    • weighted Average Number Of Shares Outstanding Basic 186,667,000
    • id REPORTED_FINANCIALS
    • key BMRN
    • subkey 10-Q
    • date 2023-04-28
    • updated 2023-04-29
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

BMRN stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001048477-23-000020
  • accounts Receivable Net Current 597,913,000
  • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 806,944,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --10,722,000
  • allocated Share Based Compensation Expense 53,695,000
  • amendment Flag false
  • assets 6,433,695,000
  • assets Current 2,842,105,000
  • cash And Cash Equivalents At Carrying Value 580,074,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 580,074,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --144,457,000
  • cik 1,048,477
  • city Area Code 415
  • common Stock Par Or Stated Value Per Share 0.001
  • common Stock Shares Authorized 500,000,000
  • common Stock Shares Issued 187,601,106
  • common Stock Shares Outstanding 187,601,106
  • comprehensive Income Net Of Tax 43,997,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-04-28
  • debt Instrument Carrying Amount 1,100,000,000
  • deferred Income Tax Expense Benefit --6,360,000
  • depreciation 10,300,000
  • depreciation Depletion And Amortization 26,421,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic 0.27
  • earnings Per Share Diluted 0.27
  • entity Address Address Line 1 770 Lindaro Street
  • entity Address City Or Town San Rafael
  • entity Address Postal Zip Code 94,901
  • entity Address State Or Province CA
  • entity Central Index Key 1,048,477
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 000-26727
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name BIOMARIN PHARMACEUTICAL INC
  • entity Registrant Name BioMarin Pharmaceutical Inc
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 68-0397820
  • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 56,757,000
  • income Tax Expense Benefit 5,905,000
  • increase Decrease In Accounts Receivable 138,796,000
  • increase Decrease In Inventories 14,098,000
  • increase Decrease In Other Operating Liabilities 4,262,000
  • interest Expense 3,703,000
  • interest Paid Net 1,437,000
  • inventory Net 918,921,000
  • irs Number 680,397,820
  • liabilities 1,774,652,000
  • liabilities And Stockholders Equity 6,433,695,000
  • liabilities Current 598,231,000
  • local Phone Number 506-6700
  • net Cash Provided By Used In Financing Activities --40,742,000
  • net Cash Provided By Used In Investing Activities --30,012,000
  • net Cash Provided By Used In Operating Activities --73,932,000
  • net Income Loss 50,852,000
  • operating Income Loss 59,347,000
  • other Assets Current 173,180,000
  • other Assets Noncurrent 150,057,000
  • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent --6,855,000
  • other Liabilities Noncurrent 92,415,000
  • other Noncash Income Expense 222,000
  • payments Related To Tax Withholding For Share Based Compensation 51,422,000
  • payments To Acquire Property Plant And Equipment 24,456,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Gross 1,875,086,000
  • property Plant And Equipment Net 1,068,142,000
  • report Link https://www.sec.gov/Archives/edgar/data/1048477/000104847723000020/bmrn-20230331_htm.xml
  • research And Development Expense 171,846,000
  • retained Earnings Accumulated Deficit --738,347,000
  • revenue From Contract With Customer Excluding Assessed Tax 596,415,000
  • selling General And Administrative Expense 223,003,000
  • share Based Compensation 53,695,000
  • stockholders Equity 4,659,043,000
  • trading Symbol BMRN
  • update 1970-01-01
  • weighted Average Number Of Diluted Shares Outstanding 194,363,000
  • weighted Average Number Of Shares Outstanding Basic 186,667,000
  • id REPORTED_FINANCIALS
  • key BMRN
  • subkey 10-Q
  • date 2023-04-28
  • updated 2023-04-29

Related News

PSI Fund That Beat SOXX by Underweighting Nvidia Now Owns the Part of the Sector That Is Breaking

PSI Fund That Beat SOXX by Underweighting Nvidia Now Owns the Part of the Sector That Is Breaking

Itai Smidt 31.08.26
Stocks Markets AMAT LRCX MU KLAC
INFQ Fails $14.50 Again as the Only Quantum Name With Real Government Revenue Trades Below Its $15 Debut

INFQ Fails $14.50 Again as the Only Quantum Name With Real Government Revenue Trades Below Its $15 Debut

Itai Smidt 31.08.26
Stocks INFQ IONQ RGTI QBTS
Centrus (LEU) Defends $185.51 as the Only U.S. Enricher Trades at 77x Earnings for 2029 Capacity

Centrus (LEU) Defends $185.51 as the Only U.S. Enricher Trades at 77x Earnings for 2029 Capacity

Itai Smidt 31.08.26
Stocks LEU OKLO SMR XE
Nuscale Fades $10.25 Again as the $750M ATM Caps Every Rally — TVA Signature Is the Only Catalyst Left

Nuscale Fades $10.25 Again as the $750M ATM Caps Every Rally — TVA Signature Is the Only Catalyst Left

Itai Smidt 31.08.26
Stocks SMR OKLO GEV CCJ
S&P 500 at 7,711, Nasdaq (IXIC) at 26,402, Dow at 53,559 — Energy Rips on $91 Brent While PG&E Craters

S&P 500 at 7,711, Nasdaq (IXIC) at 26,402, Dow at 53,559 — Energy Rips on $91 Brent While PG&E Craters

Itai Smidt 31.08.26
Stocks Markets PCG HAL CVX BMRN
Software's $14B Sector Fund Bounces While $1.5B Walks Out — Top 10 Holdings Are 62.23% At 59x Earnings

Software's $14B Sector Fund Bounces While $1.5B Walks Out — Top 10 Holdings Are 62.23% At 59x Earnings

Itai Smidt 27.08.26
Stocks Markets PLTR PANW CRWD CRWV
Trade Now
© Trading News. All Rights Reserved Since 2022